Gliotoxicity, reverse transcriptase activity and retroviral RNA in monocyte/macrophage culture supernatants from

A Ménard1, R Amouri, M Michel

  • 1INSERM, Laboratoire de Neuromodulations Interactives et Neuropathologies, Paris, France.

FEBS Letters
|August 25, 1997
PubMed

Insights

Multiple Sclerosis (MS) patients

Area of Science:

  • Neuroscience
  • Virology
  • Immunology

Background:

  • Multiple Sclerosis (MS) is a chronic neurological disease.
  • A novel retroviral agent, MSRV, has been identified in MS patients.
  • The neuropathology of MS involves gliotoxicity affecting glial cells.

Purpose of the Study:

  • To investigate the link between MSRV and MS neuropathology.
  • To determine if MSRV is associated with gliotoxicity in MS.
  • To explore the role of monocyte/macrophage culture supernatants (MMCS) in MS pathogenesis.

Main Methods:

  • Culturing monocytes/macrophages from MS patients and controls.
  • Assaying MMCS for gliotoxicity and reverse transcriptase activity.
  • Detecting MSRV-specific RNA in MMCS.

Main Results:

  • MS patient MMCS showed significant gliotoxicity and reverse transcriptase activity.
  • Gliotoxicity specifically affected astrocytes and oligodendrocytes, causing cell death.
  • Reverse transcriptase activity and MSRV RNA were present in early cultures from active MS patients.
  • MMCS from healthy controls and other neurological disease patients were negative for both.

Conclusions:

  • A correlation exists between MSRV, reverse transcriptase activity, and gliotoxicity in MS.
  • This gliotoxic factor may play a crucial role in MS etiopathogenesis.
  • Identifying the molecular form and source of the gliotoxic factor is vital for understanding MS.

Related Concept Videos